Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Katinger

Showing results (111-120 of 126) with videos related to

Pageof 13
Sort By:
Tuberculosis (Edinburgh, Scotland)|May 9, 2006
Vaccine potential of influenza vectors expressing Mycobacterium tuberculosis ESAT-6 proteinM A Stukova, S Sereinig, N V Zabolotnyh, et al.
Journal of Virology|November 1, 1995
Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgGA Trkola, A B Pomales, H Yuan, et al.
Journal of Virology|April 3, 1998
Synergistic neutralization of simian-human immunodeficiency virus SHIV-vpu+ by triple and quadruple combinations of human monoclonal antibodies and high-titer anti-human immunodeficiency virus type 1 immunoglobulinsA Li, H Katinger, M R Posner, et al.
Plant Cell Reports|November 12, 2013
Regeneration of transgenic plants of Prunus armeniaca containing the coat protein gene of Plum Pox VirusM L da Câmara Machado, A da Câmara Machado, V Hanzer, et al.
Nature Medicine|February 2, 2000
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodiesJ R Mascola, G Stiegler, T C VanCott, et al.
Journal of Virology|October 17, 2001
Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41M B Zwick, A F Labrijn, M Wang, et al.
AIDS Research and Human Retroviruses|May 20, 1997
Synergistic neutralization of a chimeric SIV/HIV type 1 virus with combinations of human anti-HIV type 1 envelope monoclonal antibodies or hyperimmune globulinsA Li, T W Baba, J Sodroski, et al.
Journal of Virology|October 1, 1996
The consequence of passive administration of an anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chimpanzees with a primary virus isolateA J Conley, J A Kessler, L J Boots, et al.
Journal of Human Virology|July 5, 2001
Potent neutralization of primary human immunodeficiency virus clade C isolates with a synergistic combination of human monoclonal antibodies raised against clade BW Xu, B A Smith-Franklin, P L Li, et al.
Journal of Virology|April 10, 1999
Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodiesJ R Mascola, M G Lewis, G Stiegler, et al.
Pageof 13

Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
Tuberculosis (Edinburgh, Scotland)|May 9, 2006
Vaccine potential of influenza vectors expressing Mycobacterium tuberculosis ESAT-6 proteinM A Stukova, S Sereinig, N V Zabolotnyh, et al.
Journal of Virology|November 1, 1995
Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgGA Trkola, A B Pomales, H Yuan, et al.
Journal of Virology|April 3, 1998
Synergistic neutralization of simian-human immunodeficiency virus SHIV-vpu+ by triple and quadruple combinations of human monoclonal antibodies and high-titer anti-human immunodeficiency virus type 1 immunoglobulinsA Li, H Katinger, M R Posner, et al.
Plant Cell Reports|November 12, 2013
Regeneration of transgenic plants of Prunus armeniaca containing the coat protein gene of Plum Pox VirusM L da Câmara Machado, A da Câmara Machado, V Hanzer, et al.
Nature Medicine|February 2, 2000
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodiesJ R Mascola, G Stiegler, T C VanCott, et al.
Journal of Virology|October 17, 2001
Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41M B Zwick, A F Labrijn, M Wang, et al.
AIDS Research and Human Retroviruses|May 20, 1997
Synergistic neutralization of a chimeric SIV/HIV type 1 virus with combinations of human anti-HIV type 1 envelope monoclonal antibodies or hyperimmune globulinsA Li, T W Baba, J Sodroski, et al.
Journal of Virology|October 1, 1996
The consequence of passive administration of an anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chimpanzees with a primary virus isolateA J Conley, J A Kessler, L J Boots, et al.
Journal of Human Virology|July 5, 2001
Potent neutralization of primary human immunodeficiency virus clade C isolates with a synergistic combination of human monoclonal antibodies raised against clade BW Xu, B A Smith-Franklin, P L Li, et al.
Journal of Virology|April 10, 1999
Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodiesJ R Mascola, M G Lewis, G Stiegler, et al.
Pageof 13